Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcin
- This topic has 0 replies, 1 voice, and was last updated 10 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
http://www.nature.com/bjc/journal/vaop/ncurrent/full/bjc2013655a.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.